11:45 PM EDT, 10/18/2026 (MT Newswires) -- H. Lundbeck (HLUN-A.CO, HLUN-B.CO) plans to appoint Lars Fruergaard Jørgensen as new chair after the company's annual general meeting in 2027. Jørgensen will succeed Dorothea Wenzel, who decided to step down at the meeting, the biopharmaceutical company said Sunday. He will initially join the Lundbeck board as an observer on Nov. 10. Jørgensen served as the chief executive officer and president of Novo Nordisk (NOVO-B.CO) from 2017 to 2025.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.